[SCI] (Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies)

[SCI] (Inactivation of Hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma)

[SCI] (Um SH BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A)

[SCI] (The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?)

[SCI] (Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma)

[SCI] (Risk Factors for Developing Hyponatremia During Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding)

[SCI] (Risk Factors for Developing Hyponatremia During Terlipressin Treatment: A Retrospective Analyses in Variceal Bleeding)

[SCI] (Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC). 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma)

[SCI] (Pancreatic mucinous cystadenoma of borderline malignancy associated with Clonorchis sinensis)

[SCI] (The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels inPatients without Hepatocellular Carcinoma)

[SCI] (Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data)

[SCI] (Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression)

[SCI] (Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years)

[SCI] (Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?)

[SCI] (Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation)

[SCI] (Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B)

[SCI] (Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line)

[SCI] (2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity)

[SCI] (Systemic cytotoxic chemotherapy of patients with advanced hepatocellular carcinoma in the era of sorafenib nonavailability)

[SCI] (Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma)

[SCI] (Is propofol safe when administered to cirrhotic patients during sedative endoscopy?)

[SCI] (Clinical implications of the titer of serum hepatitis B surface antigen during the natural history of hepatitis B virus infection)